MENU
ADMS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Adamas Pharmaceuticals (ADMS) Ownership - Who owns Adamas Pharmaceuticals?

Adamas Pharmaceuticals Inc discovers, develops, and sells therapies for chronic neurologic disorders... Show more

Profile

Industry
Pharmaceuticals Other
Address
1900 Powell Street
Phone
+1 510 450-3500
Employees
69
Web
http://www.adamaspharma.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
376.37M
P/E Ratio
N/A
Total Cash
91.37M
Projected Growth
N/A
Total Debt
135.27M
Revenue
82.47M
Risk (Beta)
2.77
Dividend Yield
N/A
Total Cash/Share
2.00
Total Debt/Equity
N/A
Revenue/Share
2.28 USD as % of share price

Fundamentals

ADMS
Capitalization
N/A
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
N/A
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
N/A
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
N/A
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of aminoadamantanes-based therapeutics for central nervous system disorders

Industry NotClassified

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1900 Powell Street
Phone
+1 510 450-3500
Employees
69
Web
http://www.adamaspharma.com